Mendelsohn, Zoe http://orcid.org/0000-0001-8619-7518
Pemberton, Hugh G. http://orcid.org/0000-0001-8419-6423
Gray, James
Goodkin, Olivia http://orcid.org/0000-0001-9283-9716
Carrasco, Ferran Prados http://orcid.org/0000-0002-7872-0142
Scheel, Michael http://orcid.org/0000-0002-3505-2914
Nawabi, Jawed http://orcid.org/0000-0002-1137-0643
Barkhof, Frederik http://orcid.org/0000-0003-3543-3706
Funding for this research was provided by:
UCLH Biomedical Research Centre
Article History
Received: 13 June 2022
Accepted: 29 September 2022
First Online: 4 November 2022
Declarations
:
: Z.M., J.G., O.G., M.S., and J.N. declare no relationships with any companies whose products or services are featured in the subject matter of the article and no relevant financial or non-financial interests to disclose. H.P. is a full-time employee of GE Healthcare. F.P.C. received a Guarantors of Brain fellowship 2017–2020. F.B. is a steering committee and iDMC member for Biogen, Merck, Roche, and EISAI; consultant for Roche, Biogen, Merck, IXICO, Jansen, and Combinostics; and has research agreements with Novartis, Merck, Biogen, GE, and Roche. F.B. is a co-founder and shareholder of Queen Square Analytics Ltd.
: Ethics approval, informed consent, consent to participate, and consent to publish were not necessary since this review paper covers public data and data provided by the companies with no human or animal data collection.